A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
Huan Ma(University of Science and Technology of China), Sandra Chiu(University of Science and Technology of China), Xiaowen Hu(Lanzhou University), Yan Wu(Chinese Academy of Sciences), Peiyi Zheng(University of Science and Technology of China), Fanwu Gong(University of Science and Technology of China), Haofeng Lin(Sun Yat-sen University), Xiangyang Chi(Academy of Military Medical Sciences), Hancong Sun(Academy of Military Medical Sciences), Zheng‐Li Shi(Chinese Academy of Sciences), Huajun Zhang(Chinese Academy of Sciences), Meihua Wang(University of Science and Technology of China), Shaohong Chen(Chinese Academy of Sciences), Changming Yu(Nanjing University of Chinese Medicine), Dan Zhao(Wuhan University), Xinghai Zhang(Chinese Academy of Sciences), Junhui Zhou(Jiangsu University), Tengchuan Jin(Anhui Medical University), Weihong Zeng(Hefei University of Technology)
Cited by 37
Related Papers
Origin and evolution of pathogenic coronaviruses
|Nature Reviews Microbiology|2018|5.8k
Characteristics of SARS-CoV-2 and COVID-19
|Nature Reviews Microbiology|2020|5.4k
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
|Nature|2013|1.9k
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
|PLoS Pathogens|2017|1k
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation
|Signal Transduction and Targeted Therapy|2020|391